Position in PTGX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$77,679
+$29,118 QoQ
Shares Held
737
+32.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CWM, LLC holds $167,669,597 across 306 Biotechnology names. PTGX ranks #110 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
66,400 | $51,303,296 | |
| 2 | MRNA |
Moderna, Inc.
|
386,906 | $19,654,824 | |
| 3 | INCY |
Incyte Corp
|
202,772 | $19,084,900 | |
| 4 | EXEL |
Exelixis, Inc.
|
263,476 | $11,300,485 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
159,652 | $9,018,741 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
181,899 | $5,038,602 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
198,333 | $4,315,726 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,609 | $3,844,262 |
All Filings in PTGX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,679 | 737 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $48,561 | 556 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $36,935 | 556 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $33,659 | 609 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $9,768 | 202 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $14,899 | 386 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $57,285 | 1,273 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $4,365 | 126 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,062 | 175 | Shares | Sole | 2024-04-05 | |
| 2023-09-30 | $116 | 7 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $193 | 7 | Shares | Sole | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||